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BACKGROUND: The resistance of bacteria causing urinary tract infection (UTI) to commonly 
prescribed antibiotics is increasing both in developing and developed countries. Resistance has emerged 
even to more potent antimicrobial agents. This study was undertaken to determine the current antibiotic 
resistance pattern among common bacterial uropathogens in St.paul’s Hospital Millennium Medical 
College. 
METHODS: Using cross sectional study design, a total of 217 female and 207 male participants were 
consecutively recruited.  Mid-urine samples were collected from all patients using wide mouthed urine 
cup. Inoculation was performed onto blood agar and MacConkey agar symoultaniously, and isolated 
organisms were identified by conventional methods. Antibiotic susceptibility was done by Kirby Bauer 
disk diffusion method. Thirteen different antibiotics representing different families of antibiotics were 
tested on all isolated organisms.  
RESULT: Of the total 424 samples, 95(22.4%) showed significant growth. Gram negative organisms 
totaled 85(20.05%), and 10(2.4%) isolates were gram positive. The most frequently isolated gram 
negative bacterium was E. coli followed by Protues and Klebsiella spp. 53(12.5%), 8(8.4%), and 7(7.4%) 
respectively. Resistance to Tetracyclin, Ampicilin, Amoxycilin and Nalidixic Acid was more than 70% of 
all isolates of E.coli strains. There was relatively low resistance rate to Nitrofurantoin, Gentamycin and 
Trimethoprim-Sulfamethoxazole. However, there was emerging resistance to Ciprofloxacilin and 
Ceftriaxone especially for common bacteruria. 
CONCLUSIONS: In this study setting, resistant  rates to Tetracyclin, Ampicilin, Amoxycilin and 
Nalidixic Acid were high. Since most isolates were sensitive for Nitrofurantoin, Gentamycin and 
Trimethoprim-Sulfamethoxazole, they are considered as appropriate antimicrobials for empirical 
treatment for urinary tract infections with the absence of culture and sensitivity setting. Increasing 
antibiotic resistance trends indicate that it is imperative to rationalize the use of antimicrobials in the 
community and use these conservatively. 
KEYWORDS: Antibiotic Resistance, Uropathogen, Addis Ababa, Ethiopia 
 
DOI: http://dx.doi.org/10.4314/ejhs.v26i2.2  
INTRODUCTION   
 
Urinary tract infection (UTI) is a term applied to a 
variety of clinical conditions ranging from 
asymptomatic presence of bacteria in the urine to  
sever form of the kidney with sepsis (1). UTIs are 
one of the most common bacterial infections in 
humans both in the community and hospital 
settings (2). Worldwide, approximately 150 
million people are diagnosed with UTIs resulting 
in 6 billion USD health care expenditures (1). 
UTIs are the most common bacterial infections 
encountered by clinicians in developing countries 
(3).  
Most UTIs are caused by Gram-negative 
bacteria like Escherichia coli (E. coli), Klebsiella 
spp., Proteus mirabilis, Pseudomonas aeruginosa, 
Acinetobacter spp., and Serratia spp. and Gram-
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positive bacteria such as Enterococcus spp. and 
Staphylococcus spp.(4). The commonest bacterial 
agent involved in causation of UTIs is Escherichia 
coli, the principal pathogen both in the community 
as well as in the hospital (5).  
The treatment of UTIs varies according to 
age, sex, underlying disease, infecting agent and 
involvement of lower or upper urinary tract. 
According to the Infectious Diseases Society of 
America (IDSA) guidelines, the recommended 
drug is Trimethoprim/sulphamethoxazole for the 
treatment of UTIs in settings where the prevalence 
of resistance is < 10-20 percent and ciprofloxacin 
is recommended where this resistance is > 20 
percent (6). The other agents used in the treatment 
of UTI include fluoroquinolones, cephalosporins 
and other β-lactams with or without β-lactamase 
inhibitors and nitrofurantoin (7).  
Drug resistance among bacteria causing UTI has 
increased since introduction to UTI chemotherapy 
(8). The etiological agents and their susceptibility 
patterns of UTI vary in regions and geographical 
locations. Besides, the etiology and drug 
resistance change through time (9). Knowledge of 
the local bacterial etiology and susceptibility 
patterns is required to trace any change that might 
have occurred in time so that They can give 
updated recommendation for optimal empirical 
therapy of UTI (10). In Ethiopia, a number of 
studies have been done on the prevalence and 
antimicrobial resistance patterns of UTIs (4, 11-
13). However, as the pattern of bacterial resistance 
is constantly changing, monitoring antimicrobial 
susceptibilities is important. It provides 
information on the pathogenic organisms isolated 
from patients, and assists in choosing the most 
appropriate empirical antimicrobial therapy. In 
addition, continuous surveys of antimicrobial 
resistance are crucial for monitoring changes in 
this resistance. The aim of this study was therefore 
to determine the resistance patterns of gram 
negative isolates from suspected UTI for the most 
commonly used antimicrobials. 
  
MATERIALS AND METHODS 
 
A cross sectional study was conducted in St.Paul’s 
Hospital Millennium Medical College 
(SPHMMC), Addis Ababa, Ethiopia. It is an urban 
setting and tertiary hospital for Ethiopian and 
teaching hospital for national and international 
students. The hospital provides out- and in-patient 
services with 370 beds. Accordingly, patients 
being seen at SPHMMC come from all over the 
Northern, Western, Southern and Eastern parts of 
Ethiopia. However, most patients seeking 
medication at SPHMMC are predominantly from 
Northern Oromia Regional State and Addis Ababa 
city administrations.  
Sample Size Calculation and Sampling 
Technique: The sample size for the study was 
calculated using the formula (n = (zα/2)2 p (1-p)/ 
d2) for estimating a single population proportion 
at 95% confidence interval (CI) (Zα/2 = 1.96), 5% 
margin of error, and 10% non-respondence rate by 
taking 50% prevalence since there is no current 
study in the setting. Therefore, the total sample 
size for this survey was 424. However, a total of 
200 pregnant women were consecutively selected 
to increase the finding or detection rates of 
cytomegalovirus infection rate in the study 
settings. 
Data Collection and Sampling Procedure: Age 
and sex have been taken from patients’ request 
forms. A total of 424 participants suspected for 
UTI were recruited using consecutive sampling 
techniques. Clean catch mid-stream urine samples 
were collected using sterile wide mouth container 
from enrolled patients. The minimum acceptable 
volume of urine sample was 10ml. All the samples 
were analyzed immediately after arrival to the 
laboratory to ensure that the pathogenic organisms 
present in the urine are isolated and to avoid over 
population of the pathogenic organism.  
Culture and Identification{ Urine specimens 
were directly inoculated onto blood agar (Oxoid, 
England) and MacConkey agar (BD, USA) using a 
sterile standard calibrated wire loop (0.001), and  
streaked culture plates were incubated at 37ºC 
aerobically for 24hrs. Number and type of colony 
count was done on blood agar plate, and then 
significant bacteriuia was determined. Cultures 
with colony counts greater than 10
5
cfu/ml, for a 
single isolated bacteria was consider significant. 
Identification of bacterial isolates was done using 
colony characteristics on blood agar, MacConkey 
agar and gram reaction of the bacteria and 
biochemical tests in accordance with standard 
procedures.  
Organisms isolated from urine specimens of 
hospitalized and outpatients over a six month 
period (August 2013 to January 2014) were 




identified and tested for antimicrobial 
susceptibilities. In this study, only samples with 
significant growth were studied (significant 
growth was defined as the presence of > 10
5
 
colony-forming units per milliliter (cfu/mL) of 
urine (14). After obtaining the pure strains, the 
strains were subjected to conventional 
biochemical identification methods to identify 
different gram-negative uropathognes.  
Antimicrobial Susceptibility Tests: According to 
the standard operational procedures, antimicrobial 
susceptibility tests were done on Mueller-Hinton 
agar (Oxoid, England) using Kirby-Bauer disk 
diffusion method (15). Briefly, using a sterile wire 
loop, 3-5 pure colonies were picked from blood 
agar plate or MacConkey agar and emulsified in 
nutrient broth (Oxoid, England) and mixed gently 
until it formed a homogenous suspension. The 
turbidity of the suspension was then adjusted to 
the optical density of McFarland 0.5 tubes in order 
to standardize the inoculums size. A sterile cotton 
swab was then dipped into the suspension and 
distributed the bacteria suspension evenly over the 
entire surface of Mueller-Hinton agar (Oxoid, 
England). The antimicrobial agents tested were: 
Ampicillin (Amp), Amoxycillin (10 µg), 
Chloramphenicol (30µg), Nalidixic Acid (NA), 
Nitrofurantoin (300 µg), Gentamicin (10µg), 
Ciprofloxacillin (5µg), Cephalothin (30µg), 
Ceftriaxone (30 µg), Norfloxacin (NOR), 
Doxycycline (30µg), Trimethoprim-
Sulfamethoxazole (25µg), and Tetracycline (30 
µg). Resistance data were interpreted according to 
Clinical Laboratory Standards Institute. Reference 
strains of E. coli ATCC 25922 and 
Staphylococcus aureus ATCC 25923 (S. aureus) 
were used for quality control for antimicrobial 
susceptibility (16). 
Data Analysis: The data was entered and 
analyzed using SPSS statistical software package 
(version 20). The descriptive statistics and 
proportion of the findings in relation with age and 
sex were computed by percentages. 
Ethical Clearance: Ethical approval was obtained 
from St. Paul’s Hospital Millennium Medical 
College Institutional Review Board (IRB). Letter 
of permission was also obtained from St.paul’s 
Hospital Millennium Medical College. Written 
and informed verbal consent was taken from study 
participants after clear explanations about the 
purpose and aims of the project were given. The 
study participants were given verbal assurance for 
the confidentiality of their responses. Based on the 





A total of 424 [217(51.2%) female and 207 
(48.8%) male] participants were enrolled. The age 
range of the participants was 1-78 years, with 
mean age of 32.8 ± 17.9 years.  Thirty five of 
them were under twenty, 62.5% between 20-35 
and 29.2% were above 36 years (Table 1).  
In August 2013 to January 2014, a total of 
424 urine specimens were examined for isolations 
and identifications of bacteria and susceptibility 
testing. Of these, 95(22.4%) urine samples showed 
significant bacterial growth, with 32/262 (12.2%), 
and 63/162 (38.9%) were pointed out for 
asymptomatic and symptomatic UTI patients 
respectively. The proportions of isolates were 
gram negative 85(20.05%), and 10(2.4%) gram 
positive. 
 
Table 1: Age and sex distribution of patients with suspected UTI in St.Paul’s Hospital Millennium Medical 
College, Addis Ababa, Ethiopia, 2013/2014. 
 
Variables Category Total (N/%) Positive (N/%)   Negative (N/%)  
Sex Female 217(51.2) 56(25.8) 161(74.2) 
Male 207(48.8) 41(19.8) 166(80.2) 
Age group ≤ 20 35(8.3) 12(34.3) 23(65.7) 
20-35 265(62.5) 49(18.5) 216(81.5) 
+ 36  124(29.2) 44(35.5) 80(64.5) 
 
 





Species of the bacteria were: E. coli 53(55.8%), 
Proteus spp. 8(8.4%), Klebsiella spp. 7(7.4%), 
Enterobacter spp. 6(6.3%), Citrobacter spp. 
5(5.3%), Providenicia spp. 3(3.2%) and 
Pseudomonas spp. 3(3.2%). Among the gram-
negative, E. coli was the most frequently isolated 
organism (62.4%) followed by Proteus spp. 
(9.4%) and Klebsiella spp. (8.2%) (Table 2). 
Resistance to DO, TE, Amp, Aml and NA was 
observed in 71.7, 83.0, 79.2, 75.5, and 73.6% of 
the E .coli isolates respectively. Low resistance 
SXT, F and CN rate was observed in 22.6, 20.8, 
and 22.6% respectively (Table 3).  
Fifty-four per cent of all E.coli isolates were 
found to be resistant to ciprofloxacin. 
Ciprofloxacin resistance was comparatively less 
among the other Gram-negative uropathogens like 
Proteus spp and Entrobacter spp, but higher in 
Klebsiella spp as mentioned (Table 1). Resistance 
to the gentamicin was also considerable especially 
among isolates of Citrobacter spp and Entrobacter 
spp with as many as 60.0, and 50.0 per cent of all 
isolates showing resistance to gentamicin 
respectively (Table 3). 
The rates of resistance among Gram-negative 
uropathogens to third generation cephalosporins 
like ceftriaxone were high. Ceftriaxone resistances 
were seen in 45.3 and 71.4 percent of all isolates 
of E. coli and Klebsilla spp respectively (Table 3). 
In this study, the overall resistance rates to 
two and more antimicrobials was 77.6%, and only 
4(4.7%) were sensitive to all antimicrobials tested. 
The resistances to two and more antimicrobial 
agents were 100.0%, 81.2%, 85.8% and 100.0% to 
Entrobacter spp., E. coli, Klebsiella, and 
Pseudomonas respectively (Table 4). 
Table 2: Frequency of isolated species among a study (n = 424) participants in St.Paul’s Hospital 
Millennium Medical College, Addis Ababa, Ethiopia, 2013/2014 
 
Bacterial Isolates n(%)  Frequency Percent 
 
Gram – positive 10(2.4) 
S.aurues 5 5.3 
S.saprofiticus  3 3.2 




Gram – negative 85 (20.05) 
E.coli spp. 53 55.8 
Proteus spp. 8 8.4 








Non-Fermenter 3 3.1 











Table 3: Antimicrobial susceptibility of bacterial isolates from patients with suspected UTI at St.Paul’s Hospital Millennium Medical College, Addis Ababa, 
Ethiopia 2013/2014. 
 
Bacteria No.isolates Amp C Aml SXT CIP CRO F CN NA KF NOR DO TE 
E.coli Spp. 53 79.2 30.2 75.5 22.6 54.7 45.3 20.8 22.6 73.6 32.1 67.9 71.7 83.0 
Proteus spp. 8 62.5 37.5 62.5 3.8 12.5 0 37.5 25.0 50.0 62.5 12.5 50.0 62.5 
Klebsiella spp. 7 85.7 57.1 71.4 57.1 57.1 71.4 42.9 28.6 42.9 71.4 71.4 71.4 28.6 
Enterobacter spp. 6 83.3 50.0 66.7 50.0 16.7 0 16.7 50.0 66.7 66.7 16.7 16.7 33.3 
Citrobacter spp. 5 60.0 20.0 80.0 40.0 40.0 20.0 40.0 60.0 60.0 40.0 20.0 60.0 80.0 
Providenicia spp. 3 66.7 0 33.3 33.3 33.3 33.3 0 33.3 66.7 33.3 33.3 66.7 100.0 
Pseudomonas spp. (n=3) 3 100.0 33.3 100.0 66.7 33.3 33.3 33.3 66.7 0 66.7 33.3 33.3 66.7 
Note: Amp=Ampicillin, Aml=Amoxycillin, C=Chloramphenicol, NA=Nalidixic Acid, F=Nitrofurantoin, CN=Gentamicin, CIP=Ciprofloxacillin, KF=Cephalothin, CRO=Ceftriaxone, 
NOR=Norfloxacin, DO=Doxycycline, SXT=Trimethoprim-Sulfamethoxazole,  TE=Tetracycline 
Table 4: Multiple antimicrobial resistance patterns of bacterial isolates from patients with suspected UTI at St.Paul’s Hospital Millennium Medical College, Addis 
Ababa, Ethiopia, 2013/2014. 
 
Bacteria R0 R1 R2 R3 R4 R5 >R6 
E.coli Spp.(n=53) 1(1.9) 9(17.0) 18(34.0) 13(24.5) 7(13.2) 2(3.8) 3(5.7) 
Proteus spp. (n=8) 0 3(37.5) 3(37.5) 1(12.5) 0 1(12.5) 0 
Klebsiella spp. (n=7) 1(14.3) 0 3(42.9) 0 0 2(28.6) 1(14.3) 
Enterobacter spp. (n=6) 0 0 0 2(33.3) 1(16.7) 1(16.7) 2(33.3) 
Citrobacter spp. (n=5) 1(20.0) 2(40.0) 0 1(20.0) 0 0 1(20.0) 
Providenicia spp. (n=3) 0 1(33.3) 1(33.3) 0 1(33.3) 0 0 
Pseudomonas spp. (n=3) 0 0 1(33.3) 0 0 0 2(66.7) 
Total isolates (n=85) 4(4.7) 15(17.6) 26(30.6) 17(20.0) 9(10.6) 6(7.1) 9(10.6) 
 







E. coli is the commonest uro-pathogen causing 
complicated and uncomplicated UTI as described 
previously (5). There are several organisms known 
to cause UTIs, including P. aeruginosa, S. 
saprophyticus, S.epidermidis, Enterococcus spp, 
P. mirabilis, Klebsiella spp., Citrobacter spp, etc. 
as reported by earlier workers (17).  
The prevalence of bacteriuria in our study 
22.4% was almost similar with what had been 
previously reported in Gondar (17.8%) (11), 
Sudan (19.5 %) (18), Nigeria (17.3%) (19) and 
Nepal (21%) (20). However, this finding is not in 
agreement with the results from studies done in 
Addis Ababa Ethiopia (10.9%) (12), and other 
parts of the world: India (32%) (21), Iraq (49.1%) 
(22). and Pakistan (51.03%) (23). The difference 
in rate of uropathogens in different studies may be 
explained by differences in methodology used, the 
environment, social habits of the community, the 
standard of personal hygiene and education.  
In this study, E. coli was by far the most 
frequently isolated bacterium that occured in 
85(20.1%) of the Gram negative organisms, 
(55.8% of all isolates). This is comparable with a 
finding in Sudan, where E. coli was 42.4% of the 
Gram negative isolate (19/9). This also goes with 
results that obtained in Tanzania where E. coli was 
38% of the Gram-negative isolates and 25% of all 
isolate (24). Likewise, many authors have the 
same findings e.g. in Pakistan and India (25, 26).  
Given that the majority of therapy for UTIs is 
empiric and that urinary tract pathogens are 
demonstrating increasing antimicrobial resistance, 
continuously updated data on antimicrobial 
susceptibility patterns is beneficial to guide 
empiric treatment. The purpose of this study was 
to describe the susceptibility profiles of isolates of 
E. coli from patients in St.Paul’s Hospital 
Millennium Medical College, Addis Ababa, 
Ethiopia. The percentage of isolates of E. coli 
resistant to ampicillin was found to be as much as 
79.2 percent in our set up. Such a high level of 
resistance to ampicillin has been quoted by many 
other studies from different parts of the world. For 
instance, studies in India showed that 80 and 76 
percent resistance strains of E. coli for ampicillin 
was observed (27, 28). In Africa (e.g. Sudan, 
Tanzania, Kenya and Senegal), it has been 
reported that, E. coli in urinary isolates have a 
high antimicrobial resistance pattern (18, 29, 30, 
31). Likewise, other studies have been reported 
high resistance of E. coli towards different 
antimicrobials was observed in Latin American 
and Costa Rica (32, 33). 
The other gram-negative isolates, Proteus 
spp., in our study showed 62.5% resistance 
towards Ampicillin and Amoxicillin, and 96.2% 
susceptibility to Trimethoprim-sulphamethoxazole 
respectively. This is different from the results 
from Gondar in which 100% resistance to 
Ampicillin and Amoxicillin-clavulanicacid and 
100% susceptible to Trimethoprim-
sulphamethoxazole (11) was reported.  
K.pneumoniae showed 85.2% resistance to 
Ampicillin. This is more or less similar with 
studies conducted in Gondar (11), Nigeria (19) 
and Libya (34).  
Multi drug resistance (MDR= resistance in 
≥2 drugs) was observed in 77.6% of the isolated 
bacterial uropathogens in this study. This is more 
or less similar with what had been found in 
previous findings reported in Ethiopia, Addis 
Ababa (71.7%) (12), but higher than a study 
carried out in Gondar (59.8%) (11). This indicates 
that multi drug resistance was found to be very 
high to the commonly used antibiotics. Antibiotic 
resistance has been recognized as the consequence 
of antibiotic use and abuse (35). Therefore, the 
reasons for this alarming event might be 
inappropriate and incorrect administration of 
antimicrobial agents in empiric therapies.  
In general, there was a high prevalence of 
gram-negative bacterial pathogens with high 
resistance patterns of commonly used antibiotics.  
However, most isolates were less resistant for 
Nitrofurantoin, Gentamycin and Trimethoprim-
Sulfamethoxazole. They are considered as 
appropriate antimicrobials for empirical treatment 
for urinary tract infections with the absence of 
culture and sensitivity setting. Increasing 
antibiotic resistance trends indicate that it is 
imperative to rationalize the use of antimicrobials 
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